NCT06164925 Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application
| NCT ID | NCT06164925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Tartu |
| Condition | Malnutrition |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-12-13 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2023-12-13 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study of aims to test whether and how the results of GLIM change when using different approaches and methods to carry out its components.
Eligibility Criteria
Inclusion Criteria: * Age of 18+ years * Able and willing to sign the consent form * Inpatients of the Tartu University Hospital * Admitted within 72 hours before enrolment Exclusion Criteria: * Age of \<18 years * Inability or refusal to sign the consent form * Pregnant or lactating women * More than 72 hours passed since admission * Patients isolating with an infection
Contact & Investigator
Alastair Forbes, MD
PRINCIPAL INVESTIGATOR
University of Tartu, Tartu University Hospital
Frequently Asked Questions
Who can join the NCT06164925 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Malnutrition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06164925 currently recruiting?
Yes, NCT06164925 is actively recruiting participants. Contact the research team at grete.kurik@ut.ee for enrollment information.
Where is the NCT06164925 trial being conducted?
This trial is being conducted at Tartu, Estonia.
Who is sponsoring the NCT06164925 clinical trial?
NCT06164925 is sponsored by University of Tartu. The principal investigator is Alastair Forbes, MD at University of Tartu, Tartu University Hospital. The trial plans to enroll 300 participants.